Skip to content

Clinical trials

Terminated Carcinoma, Non-Small-Cell Lung trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Terminated Country / region: Japan Clear all

57 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20072
20082
20092
20101
20111
20121
20141
20157
20163
20171
20185
20196
20207
20215
20225
20232
20245

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated57

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals18
Pfizer7
AbbVie4
Merck Sharp & Dohme LLC3
Astellas Pharma Global Development, Inc.2
Astellas Pharma Inc2
AstraZeneca2
Blueprint Medicines Corporation2
Hoffmann-La Roche2
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung57
Neoplasms9
Carcinoma, Renal Cell7
Lung Neoplasms7
Melanoma7
Neoplasm Metastasis7
Squamous Cell Carcinoma of Head and Neck6
Carcinoma5
Colorectal Neoplasms4
Adenocarcinoma3

Trials

Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.